| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |